Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Pio

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Cancers|July 11, 2020
DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies <i>CREBBP</i> as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)Fernando Carazo, Cristina Bértolo, Carlos Castilla, et al.
Oncotarget|November 12, 2016
Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinomaJesús Vallejo-Díaz, Manuel Olazabal-Morán, Ariel E Cariaga-Martínez, et al.
Vaccine|March 6, 2012
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responsesFrancesc Rudilla, Catherine Fayolle, Noelia Casares, et al.
Plos One|April 28, 2015
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patientsIvana Grbesa, María J Pajares, Elena Martínez-Terroba, et al.
Molecular Carcinogenesis|September 25, 2004
Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processingLaura K Zerbe, Irene Pino, Ruben Pio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 3, 2012
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progressionLeticia Corrales, Daniel Ajona, Stavros Rafail, et al.
Neoplasia (New York, N.Y.)|November 1, 2007
Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathwayDavid Blanco, Silvestre Vicent, Mario F Fraga, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 6, 2018
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancerElena Martínez-Terroba, Teresa Ezponda, Cristina Bértolo, et al.
British Journal of Cancer|May 26, 2018
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinomaCherine Abou Faycal, Elisabeth Brambilla, Jackeline Agorreta, et al.
Molecular Oncology|August 25, 2016
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancerFernando J de Miguel, María J Pajares, Elena Martínez-Terroba, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Cancers|July 11, 2020
DrugSniper, a Tool to Exploit Loss-Of-Function Screens, Identifies <i>CREBBP</i> as a Predictive Biomarker of VOLASERTIB in Small Cell Lung Carcinoma (SCLC)Fernando Carazo, Cristina Bértolo, Carlos Castilla, et al.
Oncotarget|November 12, 2016
Targeted depletion of PIK3R2 induces regression of lung squamous cell carcinomaJesús Vallejo-Díaz, Manuel Olazabal-Morán, Ariel E Cariaga-Martínez, et al.
Vaccine|March 6, 2012
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responsesFrancesc Rudilla, Catherine Fayolle, Noelia Casares, et al.
Plos One|April 28, 2015
Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patientsIvana Grbesa, María J Pajares, Elena Martínez-Terroba, et al.
Molecular Carcinogenesis|September 25, 2004
Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processingLaura K Zerbe, Irene Pino, Ruben Pio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 3, 2012
Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progressionLeticia Corrales, Daniel Ajona, Stavros Rafail, et al.
Neoplasia (New York, N.Y.)|November 1, 2007
Molecular analysis of a multistep lung cancer model induced by chronic inflammation reveals epigenetic regulation of p16 and activation of the DNA damage response pathwayDavid Blanco, Silvestre Vicent, Mario F Fraga, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 6, 2018
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancerElena Martínez-Terroba, Teresa Ezponda, Cristina Bértolo, et al.
British Journal of Cancer|May 26, 2018
The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinomaCherine Abou Faycal, Elisabeth Brambilla, Jackeline Agorreta, et al.
Molecular Oncology|August 25, 2016
A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancerFernando J de Miguel, María J Pajares, Elena Martínez-Terroba, et al.
Pageof 10